GenoScreen will be present at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) on April 13 in Amsterdam.

Sign up for our command line trainings at NGS data analysis from March 19th to 26rd, 2019.

Training schedule

GenoScreen will participate in the 1st edition of the POLEPHARMA Microbiomics Days which will be organized on April 9 & 10 at the HEALTH UFR of the University of Rouen.

On the 4th and 5th of December 2018, GenoScreen will participate at the 7th edition of the BioFIT business convention which will take place this year in Lille Grand Palais.

On March 21st, GenoScreen will participate in the "International Conference on Tuberculosis" in Brussels.

Metabiote®, the reference protocol in targeted metagenomics developed by GenoScreen, is now GCLP compliant.

GenoScreen announced today that it has completed a €1 million fundraising campaign with private investors.

Pioneer company since 2001 in sequencing, genotyping and bioinformatics, GenoScreen provides innovative services and solutions in genomics to address the needs of academic and industrial research teams. At the forefront of genomics in France, GenoScreen develops innovation programs that fuel its technological lead and generate high-performance analytical, products and control services.

pdfDownload the press release245.62 KB

Deeplex®-MycTB, was used in a study published in The Lancet Infectious Diseases highlighting the spread of tuberculosis strains resistant to first-line antibiotics, not detected by current diagnostic tests.

By continuing your visit to this site, you accept the use of statistics cookies
More information I accept